Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Ramatroban as a Novel Immunotherapy for COVID-19.

Journal of molecular and genetic medicine : an international journal of biomedical research

Gupta A, Kalantar-Zadeh K, Reddy ST.
PMID: 32952595
J Mol Genet Med. 2020;14(3). doi: 10.37421/jmgm.2020.14.457. Epub 2020 Jul 30.

SARS-CoV-2 virus suppresses host innate and adaptive immune responses, thereby allowing the virus to proliferate, and cause multiorgan failure, especially in the elderly. Respiratory viruses stimulate cyclooxygenase-2 (COX-2) to generate prostanoids including Prostaglandin D

Cite
Gupta A, Kalantar-Zadeh K, Reddy ST. Ramatroban as a Novel Immunotherapy for COVID-19. J Mol Genet Med. 2020;14(3)doi: 10.37421/jmgm.2020.14.457.
Gupta, A., Kalantar-Zadeh, K., & Reddy, S. T. (2020). Ramatroban as a Novel Immunotherapy for COVID-19. Journal of molecular and genetic medicine : an international journal of biomedical research, 14(3), . https://doi.org/10.37421/jmgm.2020.14.457
Gupta, Ajay, et al. "Ramatroban as a Novel Immunotherapy for COVID-19." Journal of molecular and genetic medicine : an international journal of biomedical research vol. 14,3 (2020). doi: https://doi.org/10.37421/jmgm.2020.14.457
Gupta A, Kalantar-Zadeh K, Reddy ST. Ramatroban as a Novel Immunotherapy for COVID-19. J Mol Genet Med. 2020;14(3). doi: 10.37421/jmgm.2020.14.457. Epub 2020 Jul 30. PMID: 32952595; PMCID: PMC7500620.
Copy Download .nbib Format: NLM
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis.

Current opinion in nephrology and hypertension

Chiang KC, Imig JD, Kalantar-Zadeh K, Gupta A.
PMID: 34846312
Curr Opin Nephrol Hypertens. 2022 Jan 01;31(1):36-46. doi: 10.1097/MNH.0000000000000750.

PURPOSE OF REVIEW: Severe COVID-19 disease is often complicated by acute kidney injury (AKI), which may transition to chronic kidney disease (CKD). Better understanding of underlying mechanisms is important in advancing therapeutic approaches.RECENT FINDINGS: SARS-CoV-2-induced endothelial injury initiates platelet...

Cite
Chiang KC, Imig JD, Kalantar-Zadeh K, et al. Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis. Curr Opin Nephrol Hypertens. 2022;31(1):36-46doi: 10.1097/MNH.0000000000000750.
Chiang, K. C., Imig, J. D., Kalantar-Zadeh, K., & Gupta, A. (2022). Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis. Current opinion in nephrology and hypertension, 31(1), 36-46. https://doi.org/10.1097/MNH.0000000000000750
Chiang, Kate C, et al. "Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis." Current opinion in nephrology and hypertension vol. 31,1 (2022): 36-46. doi: https://doi.org/10.1097/MNH.0000000000000750
Chiang KC, Imig JD, Kalantar-Zadeh K, Gupta A. Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis. Curr Opin Nephrol Hypertens. 2022 Jan 01;31(1):36-46. doi: 10.1097/MNH.0000000000000750. PMID: 34846312.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries